On December 20, 2018, the US Food and Drug Administration (FDA) issued a new warning against the use of fluoroquinolones in patients with connective tissue disorders and those predisposed to aortic disease.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Abdominal Aorta Infrarenal
January 18, 2011
Patient Selection
Renal artery stenosis (RAS) of >70% of one or both renal arteries AND
poorly controlled hypertension despite multiple antihypertensive regimen, or
January 18, 2011
Patient Selection
Indications for endovascular repair of the abdominal aortic aneurysm are:
January 18, 2011
Patient SelectionIndications for endovascular repair of the thoracic aortic aneurysm (Figure 1) are: